L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 399-405

  Yapislar, Hande ^a   Taskin, Eylem ^a  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

Author keywords

Blood pressure Physiology; Carnosine; Erythrocyte deformability physiology; Nephrectomy

Indexed keywords

CARNOSINE; KETAMINE; MALONALDEHYDE; NITRIC OXIDE; XYLAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL PRESSURE; ARTICLE; BLOOD RHEOLOGY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ERYTHROCYTE DEFORMABILITY; HEART RATE; LIPID PEROXIDATION; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; RAT; SHEAR STRESS; ULTRAFILTRATION;

ANIMALS; BLOOD PRESSURE; CARNOSINE; ERYTHROCYTE DEFORMABILITY; HEART RATE; HEMORHEOLOGY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NEPHRECTOMY; NITRATES; NITRIC OXIDE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; SHEAR STRENGTH;

EID: 84897899551     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890528     Document Type: Article

References (48)

1. Coresh J, Astor BC, Greene T et al: Prevalence of chronic kidney disease and decreased kidney function in the adult US population. Third National Health and Nutrition Examination Survey. Am J Kidney Dis, 2003; 41(1): 1-12
2. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int, 2002; 62(5): 1524-38
3. Cadenas E, Davies KJ: Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med, 2000; 29(3-4): 222-30
4. Vaziri ND, Oveisi F, Ding Y: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int, 1998; 53(6): 1748-54
5. Hasdan G, Benchetrit S, Rashid G et al: Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int, 2002; 61(2): 586-90
6. Durak I, Akyol O, Basesme E et al: Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron, 1994; 66(1): 76-80
7. Costa-Hong V, Bortolotto LA, Jorgetti V et al: Oxidative stress and endothelial dysfunction in chronic kidney disease. Arq Bras Cardiol, 2009; 92(5): 381-86, 398-403, 413-18.
8. Vaziri ND: Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens, 2004; 13(1): 93-99
9. Vessieres E, Freidja ML, Loufrani L et al: Flow (shear stress)-mediated remodeling of resistance arteries in diabetes. Vascul Pharmacol, 2012; 57(5- 6): 173-78
10. Kone BC, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol, 1997; 272(5 Pt 2): F561-78
11. van Koppen A, Verhaar MC, Bongartz LG, Joles JA: 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat. J Vis Exp, 2013; (77): e50398
12. Walshe TE, Dela Paz NG, D'Amore PA: The Role of Shear-Induced Transforming Growth Factor-beta Signaling in the Endothelium. Arterioscler Thromb Vasc Biol, 2013; 33(11): 2608-17
13. Broniowska KA, Diers AR, Corbett JA, Hogg N: Effect of nitric oxide on naphthoquinone toxicity in endothelial cells: role of bioenergetic dysfunction and poly (ADP-ribose) polymerase activation. Biochemistry, 2013; 52(25): 4364-72
14. Leung N: Hematologic manifestations of kidney disease. Semin Hematol, 2013; 50(3): 207-15
15. Kang DH, Nakagawa T, Feng L, Johnson RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol, 2002; 161(1): 239-48
16. Varin R, Mulder P, Richard V et al: Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation, 1999; 99(22): 2951-57
17. Bhagat K, Vallance P: Nitric oxide 9 years on. J R Soc Med, 1996; 89(12): 667-73
18. Bor-Kucukatay M, Wenby RB, Meiselman HJ, Baskurt OK: Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol, 2003; 284(5): H1577-84
19. Ajmani RS: Hypertension and hemorheology. Clin Hemorheol Microcirc, 1997; 17(6): 397-420
20. Hartman PE, Hartman Z, Ault KT: Scavenging of singlet molecular oxygen by imidazole compounds: high and sustained activities of carboxy terminal histidine dipeptides and exceptional activity of imidazole-4-acetic acid. Photochem Photobiol, 1990; 51(1): 59-66
21. Yapislar H, Aydogan S: Effect of carnosine on erythrocyte deformability in diabetic rats. Arch Physiol Biochem, 2012; 118(5): 265-72
22. Martinez M, Vaya A, Server R et al: Erythrocyte elongation index measured on a Rheodyn SSD laser diffractometer. Influence of the hematocrit. Clin Hemorheol Microcirc, 1998; 19(3): 255-57
23. Orpana AK, Avela K, Ranta V et al: The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia. Am J Obstet Gynecol, 1996; 174(3): 1056-60
24. An WS, Kim HJ, Cho KH, Vaziri ND: Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol, 2009; 297(4): F895-903
25. Park CH, Lee SL, Okamoto T et al: Rokumi-jio-gan-Containing Prescriptions Attenuate Oxidative Stress, Inflammation, and Apoptosis in the Remnant Kidney. Evid Based Complement Alternat Med, 2012; 2012: 587902
26. Aldini G, Orioli M, Rossoni G et al: The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med, 2011; 15(6): 1339-54
27. Kilis-Pstrusinska K: [Carnosine, carnosinase and kidney diseases]. Postepy Hig Med Dosw (Online), 2012; 66: 215-21
28. Ozdogan K, Taskin E, Dursun N: Protective effect of carnosine on adriamycin- induced oxidative heart damage in rats. Anadolu Kardiyol Derg, 2011; 11(1): 3-10
29. Dursun N, Taskin E, Ozturk F: Protection against adriamycin-induced cardiomyopathy by carnosine in rats: role of endogenous antioxidants. Biol Trace Elem Res, 2011; 143(1): 412-24
30. Freedman BI, Hicks PJ, Sale MM et al: A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant, 2007; 22(4): 1131-35
31. Kim HJ, Vaziri ND: Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol, 2010; 298(3): F662-71
32. Soetikno V, Sari FR, Lakshmanan AP et al: Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2- keap1 pathway. Mol Nutr Food Res, 2013; 57(9): 1649-59
33. Yu X, Liu H, Zou J et al: Oxidative stress in 5/6 nephrectomized rat model: effect of alpha-lipoic acid. Ren Fail, 2012; 34(7): 907-14
34. Tapia E, Sanchez-Lozada LG, Soto V et al: Sildenafil treatment prevents glomerular hypertension and hyperfiltration in rats with renal ablation. Kidney Blood Press Res, 2012; 35(4): 273-80
35. Cruz A, Rodriguez-Gomez I, Perez-Abud R et al: Effects of clofibrate on salt loading-induced hypertension in rats. J Biomed Biotechnol, 2011; 2011: 469481
36. Baskurt OK, Temiz A, Meiselman HJ: Effect of superoxide anions on red blood cell rheologic properties. Free Radic Biol Med, 1998; 24(1): 102-10
37. Hinshaw LB: Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med, 1996; 24(6): 1072-78
38. Kilic-Toprak E, Ardic F, Erken G et al: Hemorheological responses to progressive resistance exercise training in healthy young males. Med Sci Monit, 2012; 18(6): CR351-60
39. Bhavsar J, Rosenson RS: Adenosine transport, erythrocyte deformability and microvascular dysfunction: an unrecognized potential role for dipyridamole therapy. Clin Hemorheol Microcirc, 2010; 44(3): 193-205
40. Kucukatay V, Bor-Kucukatay M, Gundogdu G et al: Vitamin E treatment enhances erythrocyte deformability in aged rats. Folia Biol (Praha), 2012; 58(4): 157-65
41. Akman T, Akarsu M, Akpinar H et al: Erythrocyte deformability and oxidative stress in inflammatory bowel disease. Dig Dis Sci, 2012; 57(2): 458-64
42. Moreira-Rodrigues M, Sampaio-Maia B, Pestana M: Renal dopaminergic system activity in rat remnant kidney up to twenty-six weeks after surgery. Life Sci, 2009; 84(13-14): 409-14
43. Santos-Araujo C, Roncon-Albuquerque R Jr., Moreira-Rodrigues M et al: Local modulation of the natriuretic peptide system in the rat remnant kidney. Nephrol Dial Transplant, 2009; 24(6): 1774-82
44. Quelhas-Santos J, Sampaio-Maia B, Simoes-Silva L et al: Sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney. J Hypertens, 2013; 31(3): 543-52; discussion 52-53
45. Lai EY, Solis G, Luo Z et al: p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice. Hypertension, 2012; 59(2): 415-20
46. Lai EY, Onozato ML, Solis G et al: Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass. Hypertension, 2010; 55(4): 983-89
47. Franco V, Oparil S: Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr, 2006; 25(3 Suppl.): 247S-55S
48. Zaloga GP, Roberts PR, Black KW et al: Carnosine is a novel peptide modulator of intracellular calcium and contractility in cardiac cells. Am J Physiol, 1997; 272(1 Pt 2): H462-68